SCHEMBL803768

SCHEMBL803768

CN(C(=O)c1cc(F)ccc1Cl)[C@@H]1CCc2ccc(C(=O)O)cc21

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 2/20 0.43
KDM4A O75164 1/20 0.38
KDM4C Q9H3R0 1/20 0.38
HTR2C P28335 1/20 0.36
KCNH2 Q12809 1/20 0.36
MCHR1 Q99705 1/20 0.36
PIN1 Q13526 2/20 0.36
ACHE P22303 1/20 0.36
PDK1 Q15118 3/20 0.36
PDK2 Q15119 3/20 0.36
PDK3 Q15120 3/20 0.36
PDK4 Q16654 3/20 0.36
SLC6A4 P31645 2/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A3 Q01959 1/20 0.35
PYGL P06737 1/20 0.35
DRD3 P35462 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL784876 1.00 TRPM8 (0.43) TRPM8KDM4AKDM4CHTR2CKCNH2
SCHEMBL785078 0.91 TRPM8 (0.43) TRPM8KDM4AKDM4CHTR2CKCNH2
SCHEMBL785630 0.91 TRPM8 (0.43) TRPM8KDM4AKDM4CHTR2CKCNH2
SCHEMBL803553 0.89 TRPM8 (0.39) TRPM8PIN1ACHESLC6A4SLC6A2
SCHEMBL784506 0.88 TRPM8 (0.41) TRPM8KDM4AKDM4CHTR2CKCNH2
SCHEMBL784897 0.88 TRPM8 (0.47) TRPM8KDM4AKDM4CPIN1PDK1
SCHEMBL784507 0.88 TRPM8 (0.41) TRPM8KDM4AKDM4CHTR2CKCNH2
SCHEMBL803263 0.88 TRPM8 (0.47) TRPM8KDM4AKDM4CPIN1PDK1
SCHEMBL484622 0.87 HPGD (0.49) TRPM8PYGLDRD3
SCHEMBL785069 0.87 HPGD (0.49) TRPM8PYGLDRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
WO-2012038081-A1 SUBSTITUTED BENZAMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-03-29 WO disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071461-A1 Substituted Benzamide Compounds BDKRB1, BDKRB2, HRH2 TRPM8 180/4885KDM4A 2438/4885KDM4C 2027/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.